SAKAR

SAKAR HEALTHCARE

Small Cap BSE: sakar NSE: SAKAR
₹203.1
0.2 (0.1%)
As on 30 September, 2022 | 02:19

Sakar Healthcare Share Price

Sakar Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SAKAR HEALTHCARE

Start SIP

Sakar Healthcare Share Returns

  • Over 1 Month -4.11%
  • Over 3 Month 23.54%
  • Over 6 Month 46.01%
  • Over 1 Year 27.02%

Sakar Healthcare Key Statistics

P/E Ratio 24.1
PEG Ratio 1.1
Market Cap Cr 378
Price to Book Ratio 2.7
EPS 8.2
Dividend 0
Relative Strength Index 41.41
Money Flow Index 63.06
MACD Signal 6.02
Average True Range 12.8

Sakar Healthcare Investment Rating

  • Master Rating:
  • Sakar Healthcare has an operating revenue of Rs. 126.50 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 15% is great, ROE of 11% is good. The company has a debt to equity of 67%, which is bit higher. The stock from a technical standpoint is trading below to its 50DMA and around 26% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 76 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 293730323022
Operating Expenses Qtr Cr 212723252415
Operating Profit Qtr Cr 897767
Depreciation Qtr Cr 433225
Interest Qtr Cr 111100
Tax Qtr Cr 1-33300
Net Profit Qtr Cr 390242

Sakar Healthcare Technicals

EMA & SMA

Current Price
203.1
0.2 (0.1%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 217.84
  • 50 Day
  • 206.57
  • 100 Day
  • 189.51
  • 200 Day
  • 160.45
  • 20 Day
  • 224.23
  • 50 Day
  • 207.92
  • 100 Day
  • 182.81
  • 200 Day
  • 160.29

Sakar Healthcare Resistance and Support

PIVOT
₹203.9
Resistance
First Resistance 207.65
Second Resistance 212.4
Third Resistance 216.15
RSI 41.41
MFI 63.06
MACD Single Line 6.02
MACD 1.57
Support
First Resistance 199.15
Second Resistance 195.4
Third Resistance 190.65

Sakar Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 19,580 1,184,198 60.48
Week 23,076 1,525,541 66.11
1 Month 37,263 3,082,780 82.73
6 Month 46,870 2,979,050 63.56

Sakar Healthcare Result Highlights

Sakar Healthcare Synopsis

NSE-Medical-Ethical Drugs

Sakar Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 128.23 Cr. and Equity Capital is Rs. 17.12 Cr. for the Year ended 31/03/2022. Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861.
Market Cap 378
Sales 127
Shares in Float 0.71
No of funds 1
Yield
Book Value 2.73
U/D Vol ratio 1
LTDebt / Equity 67
Alpha 0.17
Beta 1.09

Sakar Healthcare

Owner NameJul-22Jun-22Mar-22Dec-21
Promoters 62.1%67.54%67.54%
Foreign Portfolio Investors 16.11%8.76%8.76%
Others 21.79%23.7%23.7%

Sakar Healthcare Management

Name Designation
Mr. Sanjay S Shah Chairman & Managing Director
Mr. Aarsh S Shah Joint Managing Director
Ms. Rita S Shah Whole Time Director
Mr. Shailesh B Patel Ind. Non-Executive Director
Mr. Prashant C Srivastav Ind. Non-Executive Director
Mr. Hemendra C Shah Ind. Non-Executive Director

Sakar Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sakar Healthcare Corporate Action

Date Purpose Remarks
2022-08-06 Quarterly Results
2022-07-08 Others Other business matters
2022-05-20 Audited Results
2022-02-08 Quarterly Results
2021-10-29 Quarterly Results

Sakar Healthcare FAQs

What is Share Price of Sakar Healthcare ?

Sakar Healthcare share price is ₹203 As on 30 September, 2022 | 02:05

What is the Market Cap of Sakar Healthcare ?

The Market Cap of Sakar Healthcare is ₹378.1 Cr As on 30 September, 2022 | 02:05

What is the P/E ratio of Sakar Healthcare ?

The P/E ratio of Sakar Healthcare is 24.1 As on 30 September, 2022 | 02:05

What is the PB ratio of Sakar Healthcare ?

The PB ratio of Sakar Healthcare is 2.7 As on 30 September, 2022 | 02:05

Q1FY23